It is currently 23 Jun 2017, 11:02

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# Events & Promotions

###### Events & Promotions in June
Open Detailed Calendar

# A pharmaceutical company received $3 million in royalties on  post reply Question banks Downloads My Bookmarks Reviews Important topics Author Message Intern Joined: 08 May 2006 Posts: 19 A pharmaceutical company received$3 million in royalties on [#permalink]

### Show Tags

20 Aug 2006, 21:18
00:00

Difficulty:

(N/A)

Question Stats:

100% (03:17) correct 0% (00:00) wrong based on 1 sessions

### HideShow timer Statistics

This topic is locked. If you want to discuss this question please re-post it in the respective forum.

A pharmaceutical company received $3 million in royalties on the first$20 million in
sales of the generic equivalent of one of its products and then $9 million in royalties on the next$108 million in sales. By approximately what percent did the ratio of royalties
to sales decrease from the first $20 million in sales to the next$108 million in sales?
A. 8%
B. 15%
C. 45%
D. 52%
E. 56%
Senior Manager
Joined: 19 Jul 2006
Posts: 358

### Show Tags

21 Aug 2006, 00:30
C

3/20=0.15

9/108=.0833

Req. % = (0.15 -0.0833)/0.15 = ~ 45%
21 Aug 2006, 00:30
Display posts from previous: Sort by

# A pharmaceutical company received \$3 million in royalties on

 post reply Question banks Downloads My Bookmarks Reviews Important topics

 Powered by phpBB © phpBB Group and phpBB SEO Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.